189
views
0
recommends
+1 Recommend
0 collections
    19
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease

      research-article
      1 , 2 , 3 , 4 , 1 , 2 , 3 , 4 , 1 , 2 , 3 , 4 , 1 , 2 , 3 , 4 , 1 , 2 , 3 , 4 , 1 , 2 , 3 , 4 , 5 , 1 , 2 , 3 , 4 , 6 , 1 , 2 , 3 , 4 , 6 , 1 , 2 , 3 , 4 , 6 , 1 , 2 , 3 , 4 , 6 , 1 , 2 , 3 , 4 , 1 , 2 , 3 , 4 ,
      Gut
      BMJ Group
      C Reactive protein, mesenteric fat, bacterial translocation, Crohn's disease, IBD basic research, 6-mercaptopurine, bacterial translocation, IBD, thiopurine methyltransferase, antibacterial peptide, IBD models, azathioprine, IBD clinical, 2,4,6-trinitrobenzene sulfonic acid, acute hepatitis, alcoholic liver disease, anti-bacterial mucosal immunity, gut inflammation, anti-bacterial peptide, antibiotic therapy, antibiotics: clinical trials, bacteraemia, bacterial overgrowth, bacterial translocation, bacterial infection, bacterial pathogenesis, bacterial adherence, crohn's disease, TNF-alpha, ulcerative colitis, small intestine, cell biology, inflammatory bowel disease, mucosal immunology, Helicobacter pylori, non-ulcer dyspepsia, genetic polymorphisms, gastric neoplasia, non-alcoholic steatohepatitis, gut inflammation, alcoholic liver disease, cytokines

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          Mesenteric fat hyperplasia is a hallmark of Crohn's disease (CD), and C reactive protein (CRP) is correlated with disease activity. The authors investigated whether mesenteric adipocytes may be a source of CRP in CD and whether inflammatory and bacterial triggers may stimulate its production by adipocytes.

          Design

          CRP expression in the mesenteric and subcutaneous fats of patients with CD and the correlation between CRP plasma concentrations and mesenteric messenger RNA (mRNA) levels were assessed. The impact of inflammatory and bacterial challenges on CRP synthesis was tested using an adipocyte cell line. Bacterial translocation to mesenteric fat was studied in experimental models of colitis and ileitis and in patients with CD.

          Results

          CRP expression was increased in the mesenteric fat of patients with CD, with mRNA levels being 80±40 (p<0.05) and 140±65 (p=0.04) times higher than in the mesenteric fat of patients with ulcerative colitis and in the subcutaneous fat of the same CD subjects, respectively, and correlated with plasma levels. Escherichia coli (1230±175-fold, p<0.01), lipopolysaccharide (26±0.5-fold, p<0.01), tumour necrosis factor α (15±0.3-fold, p<0.01) and interleukin-6 (10±0.7-fold, p<0.05) increased CRP mRNA levels in adipocyte 3T3-L1 cells. Bacterial translocation to mesenteric fat occurred in 13% and 27% of healthy and CD subjects, respectively, and was increased in experimental colitis and ileitis. Human mesenteric adipocytes constitutively expressed mRNA for TLR2, TLR4, NOD1 and NOD2.

          Conclusion

          Mesenteric fat is an important source of CRP in CD. CRP production by mesenteric adipocytes may be triggered by local inflammation and bacterial translocation to mesenteric fat, providing a mechanism whereby mesenteric fat hyperplasia may contribute to inflammatory response in CD.

          Related collections

          Most cited references32

          • Record: found
          • Abstract: found
          • Article: not found

          An integrated view of humoral innate immunity: pentraxins as a paradigm.

          The innate immune system consists of a cellular and a humoral arm. Pentraxins (e.g., the short pentraxin C reactive protein and the long pentraxin PTX3) are key components of the humoral arm of innate immunity which also includes complement components, collectins, and ficolins. In response to microorganisms and tissue damage, neutrophils, macrophages, and dendritic cells are major sources of fluid-phase pattern-recognition molecules (PRMs) belonging to different molecular classes. Humoral PRMs in turn interact with and regulate cellular effectors. Effector mechanisms of the humoral innate immune system include activation and regulation of the complement cascade; agglutination and neutralization; facilitation of recognition via cellular receptors (opsonization); and regulation of inflammation. Thus, the humoral arm of innate immunity is an integrated system consisting of different molecules and sharing functional outputs with antibodies.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue.

            High-sensitive C-reactive protein (hs-CRP) is a well-known risk factor for coronary artery disease (CAD). Recently, we have demonstrated that adiponectin served as an antiatherogenic plasma protein which was secreted specifically from adipocytes. The present study investigated the association between adiponectin and CRP in the blood stream and adipose tissue. We studied a total of 101 male patients, 71 of whom had angiographically documented coronary atherosclerosis. As a control group, 30 patients with normal coronary angiogram were included. The plasma hs-CRP levels were negatively correlated with the plasma adiponectin levels (r=-0.29, P<0.01). The plasma adiponectin concentrations were significantly lower and the hs-CRP levels were significantly higher in the CAD patients compared with control subjects. The mRNA levels of CRP and adiponectin were analyzed by quantitative real-time polymerase chain reaction method. We found that the CRP mRNA was expressed in human adipose tissue. A significant inverse correlation was observed between the CRP and adiponectin mRNA levels in human adipose tissue (r=-0.89, P<0.01). In addition, the CRP mRNA level of white adipose tissue in adiponectin deficient mice was higher than that of wild-type mice. The reciprocal association of adiponectin and CRP levels in both human plasma and adipose tissue might participate in the development of atherosclerosis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.

              C-reactive protein (CRP) levels are often used in the follow-up of patients with inflammatory bowel disease (IBD). The aims of this study were to establish the relationship of CRP levels to disease extent in patients with ulcerative colitis and to phenotype in patients with Crohn's disease, and to investigate the predictive value of CRP levels for disease outcome. CRP was measured at diagnosis and after 1 and 5 years in patients diagnosed with IBD in south-eastern Norway. After 5 years, 454 patients with ulcerative colitis and 200 with Crohn's disease were alive and provided sufficient data for analysis. Patients with Crohn's disease had a stronger CRP response than did those with ulcerative colitis. In patients with ulcerative colitis, CRP levels at diagnosis increased with increasing extent of disease. No differences in CRP levels at diagnosis were found between subgroups of patients with Crohn's disease as defined according to the Vienna classification. In patients with ulcerative colitis with extensive colitis, CRP levels above 23 mg/l at diagnosis predicted an increased risk of surgery (odds ratio (OR) 4.8, 95% confidence interval (CI) 1.5 to 15.1, p = 0.02). In patients with ulcerative colitis, CRP levels above 10 mg/l after 1 year predicted an increased risk of surgery during the subsequent 4 years (OR 3.0, 95% CI 1.1 to 7.8, p = 0.02). A significant association between CRP levels at diagnosis and risk of surgery was found in patients with Crohn's disease and terminal ileitis (L1), and the risk increased when CRP levels were above 53 mg/l in this subgroup (OR 6.0, 95% CI 1.1 to 31.9, p = 0.03). CRP levels at diagnosis were related to the extent of disease in patients with ulcerative colitis. Phenotype had no influence on CRP levels in patients with Crohn's disease. CRP is a predictor of surgery in subgroups of patients with either ulcerative colitis or Crohn's disease.
                Bookmark

                Author and article information

                Journal
                Gut
                gut
                gutjnl
                Gut
                BMJ Group (BMA House, Tavistock Square, London, WC1H 9JR )
                0017-5749
                1468-3288
                21 September 2011
                January 2012
                21 September 2011
                : 61
                : 1
                : 78-85
                Affiliations
                [1 ]Universitè Lille Nord de France, Lille, France
                [2 ]Inserm U995, Lille, France
                [3 ]UDSL, Lille, France
                [4 ]Service des Maladies de l'Appareil Digestif et de la Nutrition, CHU Lille, Lille, France
                [5 ]Service de Chirurgie Adultes Ouest, CHU Lille, Lille, France
                [6 ]Laboratoire de Bactériologie Clinique, Faculté de Pharmacie de Lille, Lille, France
                Author notes
                Correspondence to Professor Pierre Desreumaux, Inserm U995, Faculté de Médecine Pôle Recherche, Amphi J-K, Bld du Pr Jules Leclercq, F-59045 Lille Cedex, France; pdesreumaux@ 123456hotmail.com

                See Commentary, p [Related article:]3

                Article
                gutjnl-2011-300370
                10.1136/gutjnl-2011-300370
                3230831
                21940721
                be616e7c-b340-4be4-918a-8ecfe1ef4668
                © 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

                This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.

                History
                : 10 August 2011
                : 17 August 2011
                Categories
                Inflammatory Bowel Disease
                1506
                Original article

                Gastroenterology & Hepatology
                thiopurine methyltransferase,mucosal immunology,mesenteric fat,crohn's disease,helicobacter pylori,bacterial pathogenesis,non-alcoholic steatohepatitis,non-ulcer dyspepsia,bacterial overgrowth,alcoholic liver disease,anti-bacterial mucosal immunity,ibd basic research,gut inflammation,ibd clinical,ibd,bacterial adherence,6-mercaptopurine,small intestine,gastric neoplasia,cytokines,cell biology,azathioprine,antibiotics: clinical trials,bacterial translocation,antibiotic therapy,bacterial infection,bacteraemia,anti-bacterial peptide,2,4,6-trinitrobenzene sulfonic acid,c reactive protein,ibd models,antibacterial peptide,tnf-alpha,inflammatory bowel disease,ulcerative colitis,genetic polymorphisms,acute hepatitis

                Comments

                Comment on this article